Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Flyvbjerg

Showing results (71-80 of 284) with videos related to

Pageof 29
Sort By:
Journal of Psychiatric Research|October 18, 2008
Leptin, ghrelin, and endocannabinoids: potential therapeutic targets in anorexia nervosaRené Klinkby Støving, Alin Andries, Kim Brixen, et al.
Biogerontology|August 12, 2015
Telomerase activity promotes osteoblast differentiation by modulating IGF-signaling pathwayHamid Saeed, Weimin Qiu, Chen Li, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 5, 2003
The emerging role of VEGF in diabetic kidney diseaseMogher Khamaisi, Bieke F Schrijvers, An S De Vriese, et al.
Circulation|June 5, 2003
Low serum insulin-like growth factor I is associated with increased risk of ischemic heart diseaseRainer H Boger, Jan Frystyk, Thomas Ledet, et al.
Clinical Laboratory|May 16, 2015
Soluble receptor of advanced glycation end-products in patients with acute myocardial infarction treated with remote ischaemic conditioningLouise Jung Nørgaard Jensen, Kim Munk, Allan Flyvbjerg, et al.
International Journal of Experimental Diabetes Research|January 28, 2003
Effect of mild hypoinsulinemia on renal hypertrophy: growth hormone/insulin-like growth factor I system in mild streptozotocin diabetesMogher Khamaisi, Allan Flyvbjerg, Ziv Haramati, et al.
International Journal of Experimental Pathology|March 8, 2014
Effects of long-acting somatostatin analogues on redox systems in rat lens in experimental diabetesSirilaksana Kunjara, A Leslie Greenbaum, Milena Sochor, et al.
Hormones (Athens, Greece)|September 20, 2006
The effect of long-term somatostatin analogue treatment on free and total insulin-like growth factor (IGF) -I, -II and IGF binding protein -1, -2 and -3 serum levels in euthyroid patients with active thyroid eye diseaseGerasimos Krassas, Nikolaos Pontikides, Argyrios Dumas, et al.
Frontiers in Endocrinology|January 23, 2023
Adiponectin, IGFBP-1 and -2 are independent predictors in forecasting prediabetes and type 2 diabetesKerstin Brismar, Agneta Hilding, Ishrath Ansurudeen, et al.
The Journal of Infection|October 27, 2005
Growth factors, glucose and insulin kinetics after low dose growth hormone therapy in HIV-lipodystrophySteen B Haugaard, Ove Andersen, Allan Flyvbjerg, et al.
Pageof 29

Showing results (71-80 of 284) with videos related to

Sort By:
Pageof 29
Journal of Psychiatric Research|October 18, 2008
Leptin, ghrelin, and endocannabinoids: potential therapeutic targets in anorexia nervosaRené Klinkby Støving, Alin Andries, Kim Brixen, et al.
Biogerontology|August 12, 2015
Telomerase activity promotes osteoblast differentiation by modulating IGF-signaling pathwayHamid Saeed, Weimin Qiu, Chen Li, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 5, 2003
The emerging role of VEGF in diabetic kidney diseaseMogher Khamaisi, Bieke F Schrijvers, An S De Vriese, et al.
Circulation|June 5, 2003
Low serum insulin-like growth factor I is associated with increased risk of ischemic heart diseaseRainer H Boger, Jan Frystyk, Thomas Ledet, et al.
Clinical Laboratory|May 16, 2015
Soluble receptor of advanced glycation end-products in patients with acute myocardial infarction treated with remote ischaemic conditioningLouise Jung Nørgaard Jensen, Kim Munk, Allan Flyvbjerg, et al.
International Journal of Experimental Diabetes Research|January 28, 2003
Effect of mild hypoinsulinemia on renal hypertrophy: growth hormone/insulin-like growth factor I system in mild streptozotocin diabetesMogher Khamaisi, Allan Flyvbjerg, Ziv Haramati, et al.
International Journal of Experimental Pathology|March 8, 2014
Effects of long-acting somatostatin analogues on redox systems in rat lens in experimental diabetesSirilaksana Kunjara, A Leslie Greenbaum, Milena Sochor, et al.
Hormones (Athens, Greece)|September 20, 2006
The effect of long-term somatostatin analogue treatment on free and total insulin-like growth factor (IGF) -I, -II and IGF binding protein -1, -2 and -3 serum levels in euthyroid patients with active thyroid eye diseaseGerasimos Krassas, Nikolaos Pontikides, Argyrios Dumas, et al.
Frontiers in Endocrinology|January 23, 2023
Adiponectin, IGFBP-1 and -2 are independent predictors in forecasting prediabetes and type 2 diabetesKerstin Brismar, Agneta Hilding, Ishrath Ansurudeen, et al.
The Journal of Infection|October 27, 2005
Growth factors, glucose and insulin kinetics after low dose growth hormone therapy in HIV-lipodystrophySteen B Haugaard, Ove Andersen, Allan Flyvbjerg, et al.
Pageof 29